Literature DB >> 12498377

Localization of glucocorticoid receptors in the murine inner ear.

Toshiki Shimazaki1, Issei Ichimiya, Masashi Suzuki, Goro Mogi.   

Abstract

We performed an immunohistochemical investigation of the distribution of glucocorticoid receptors (GRs) in the murine inner ear and found that GRs were expressed extensively, but with various degrees of immunoreactivity in different regions. We observed the strongest GR expression in the type III fibrocytes of the spiral ligament. Although the immunoreactivity of the cochlear hair cells and of the vestibular sensory epithelia was weak, the neighboring cochlear supporting cells and the subepithelial regions of the vestibular sensory epithelia were immunostained. Staining for GRs was also positive in the spiral ganglia and vestibular ganglia, as well as in the endolymphatic sac. The role of GRs in the inner ear is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12498377     DOI: 10.1177/000348940211101213

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  15 in total

1.  Old mice lacking high-affinity nicotine receptors resist acoustic trauma.

Authors:  Haiyan Shen; Zhaoyu Lin; Debin Lei; Josiah Han; Kevin K Ohlemiller; Jianxin Bao
Journal:  Hear Res       Date:  2011-01-25       Impact factor: 3.208

Review 2.  [The significance of stress: its role in the auditory system and the pathogenesis of tinnitus].

Authors:  B Mazurek; T Stöver; H Haupt; B F Klapp; M Adli; J Gross; A J Szczepek
Journal:  HNO       Date:  2010-02       Impact factor: 1.284

3.  Alternatives to systemic steroid therapy for refractory immune-mediated inner ear disease: A physiopathologic approach.

Authors:  José Ramón García-Berrocal; Andrés Ibáñez; Antonio Rodríguez; José Angel González-García; José María Verdaguer; Almudena Trinidad; Rafael Ramírez-Camacho
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-06-27       Impact factor: 2.503

4.  Prophylactic and therapeutic functions of drug combinations against noise-induced hearing loss.

Authors:  Jianxin Bao; Michelle Hungerford; Randi Luxmore; Dalian Ding; Ziyu Qiu; Debin Lei; Aizhen Yang; Ruqiang Liang; Kevin K Ohlemiller
Journal:  Hear Res       Date:  2013-06-18       Impact factor: 3.208

Review 5.  The cochlear CRF signaling systems and their mechanisms of action in modulating cochlear sensitivity and protection against trauma.

Authors:  Christine E Graham; Johnvesly Basappa; Sevin Turcan; Douglas E Vetter
Journal:  Mol Neurobiol       Date:  2011-09-11       Impact factor: 5.590

Review 6.  The cochlea as an independent neuroendocrine organ: expression and possible roles of a local hypothalamic-pituitary-adrenal axis-equivalent signaling system.

Authors:  Johnvesly Basappa; Christine E Graham; Sevin Turcan; Douglas E Vetter
Journal:  Hear Res       Date:  2012-03-29       Impact factor: 3.208

Review 7.  Corticosteroid therapy for hearing and balance disorders.

Authors:  Dennis R Trune; Barbara Canlon
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

8.  Blocking the glucocorticoid receptor with RU-486 does not prevent glucocorticoid control of autoimmune mouse hearing loss.

Authors:  Dennis R Trune; J Beth Kempton
Journal:  Audiol Neurootol       Date:  2009-11-16       Impact factor: 1.854

9.  Expression and dexamethasone-induced nuclear translocation of glucocorticoid and mineralocorticoid receptors in guinea pig cochlear cells.

Authors:  Sung-Hee Kil; Federico Kalinec
Journal:  Hear Res       Date:  2013-02-09       Impact factor: 3.208

10.  In CEM cells the autosomal deafness gene dfna5 is regulated by glucocorticoids and forskolin.

Authors:  M S Webb; A L Miller; E Brad Thompson
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.